Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phthalic Acids | 44 | 2024 | 475 | 4.750 |
Why?
|
Environmental Pollutants | 55 | 2024 | 1251 | 4.630 |
Why?
|
Pregnancy Complications, Infectious | 51 | 2024 | 2123 | 4.320 |
Why?
|
Infectious Disease Transmission, Vertical | 46 | 2023 | 1349 | 4.270 |
Why?
|
HIV Infections | 146 | 2024 | 17126 | 4.110 |
Why?
|
Anti-Retroviral Agents | 34 | 2024 | 1780 | 3.470 |
Why?
|
Phenols | 26 | 2024 | 513 | 2.730 |
Why?
|
Anti-HIV Agents | 41 | 2024 | 4490 | 2.110 |
Why?
|
Maternal Exposure | 25 | 2024 | 1036 | 2.110 |
Why?
|
Semen | 14 | 2023 | 346 | 2.060 |
Why?
|
Pregnancy | 187 | 2024 | 29650 | 1.870 |
Why?
|
Parabens | 16 | 2023 | 114 | 1.830 |
Why?
|
Lead | 9 | 2022 | 871 | 1.720 |
Why?
|
Antiretroviral Therapy, Highly Active | 32 | 2020 | 1894 | 1.710 |
Why?
|
Polychlorinated Biphenyls | 16 | 2022 | 235 | 1.660 |
Why?
|
Reproductive Techniques, Assisted | 20 | 2022 | 496 | 1.650 |
Why?
|
Semen Analysis | 18 | 2023 | 230 | 1.640 |
Why?
|
Fertilization in Vitro | 30 | 2020 | 1296 | 1.630 |
Why?
|
Environmental Exposure | 48 | 2024 | 4389 | 1.630 |
Why?
|
Infertility, Female | 17 | 2023 | 762 | 1.540 |
Why?
|
Diethylhexyl Phthalate | 10 | 2023 | 83 | 1.470 |
Why?
|
Infertility | 16 | 2022 | 654 | 1.450 |
Why?
|
Paternal Exposure | 11 | 2021 | 94 | 1.430 |
Why?
|
Premature Birth | 22 | 2023 | 1762 | 1.410 |
Why?
|
Prenatal Exposure Delayed Effects | 24 | 2020 | 2484 | 1.410 |
Why?
|
Dioxins | 12 | 2022 | 92 | 1.360 |
Why?
|
Benzhydryl Compounds | 19 | 2024 | 942 | 1.340 |
Why?
|
Puberty | 13 | 2022 | 498 | 1.340 |
Why?
|
Pregnancy Outcome | 31 | 2024 | 2901 | 1.330 |
Why?
|
Acquired Immunodeficiency Syndrome | 12 | 2023 | 2198 | 1.270 |
Why?
|
HIV | 9 | 2022 | 1579 | 1.210 |
Why?
|
Sexual Maturation | 7 | 2019 | 260 | 1.170 |
Why?
|
Endocrine Disruptors | 10 | 2024 | 263 | 1.110 |
Why?
|
Prospective Studies | 138 | 2024 | 54190 | 1.060 |
Why?
|
Abnormalities, Drug-Induced | 7 | 2024 | 338 | 1.030 |
Why?
|
Russia | 26 | 2022 | 381 | 0.980 |
Why?
|
Live Birth | 15 | 2021 | 513 | 0.970 |
Why?
|
Infertility, Male | 10 | 2019 | 396 | 0.950 |
Why?
|
Flame Retardants | 7 | 2020 | 92 | 0.910 |
Why?
|
Female | 311 | 2024 | 390174 | 0.860 |
Why?
|
Sperm Count | 13 | 2023 | 228 | 0.840 |
Why?
|
Child | 131 | 2024 | 79604 | 0.810 |
Why?
|
Abortion, Spontaneous | 9 | 2020 | 529 | 0.790 |
Why?
|
Puberty, Delayed | 2 | 2013 | 121 | 0.740 |
Why?
|
Maternal-Fetal Exchange | 9 | 2018 | 460 | 0.740 |
Why?
|
Child Development | 16 | 2020 | 2274 | 0.740 |
Why?
|
Adolescent | 133 | 2024 | 87551 | 0.730 |
Why?
|
Humans | 384 | 2024 | 759098 | 0.730 |
Why?
|
Models, Statistical | 6 | 2023 | 5067 | 0.720 |
Why?
|
Adult | 196 | 2024 | 219353 | 0.690 |
Why?
|
Infant, Newborn | 60 | 2024 | 26099 | 0.670 |
Why?
|
Hydrocarbons, Chlorinated | 7 | 2020 | 119 | 0.670 |
Why?
|
CD4 Lymphocyte Count | 24 | 2021 | 2569 | 0.650 |
Why?
|
Microcephaly | 2 | 2020 | 422 | 0.640 |
Why?
|
Cohort Studies | 82 | 2023 | 41266 | 0.640 |
Why?
|
Ovarian Follicle | 7 | 2023 | 242 | 0.640 |
Why?
|
Young Adult | 100 | 2024 | 58477 | 0.630 |
Why?
|
Reproduction | 12 | 2021 | 646 | 0.620 |
Why?
|
Viral Load | 22 | 2022 | 3317 | 0.620 |
Why?
|
HIV-1 | 17 | 2022 | 6848 | 0.620 |
Why?
|
Environmental Health | 8 | 2018 | 282 | 0.610 |
Why?
|
Spermatozoa | 8 | 2019 | 633 | 0.610 |
Why?
|
Pregnancy Trimester, First | 11 | 2024 | 907 | 0.610 |
Why?
|
Fertility | 11 | 2021 | 775 | 0.600 |
Why?
|
Pesticides | 8 | 2020 | 290 | 0.600 |
Why?
|
Cosmetics | 4 | 2023 | 102 | 0.600 |
Why?
|
Sperm Motility | 10 | 2023 | 266 | 0.590 |
Why?
|
Reverse Transcriptase Inhibitors | 10 | 2022 | 618 | 0.580 |
Why?
|
Male | 213 | 2024 | 358602 | 0.570 |
Why?
|
Birth Weight | 8 | 2023 | 2085 | 0.560 |
Why?
|
Adolescent Development | 3 | 2018 | 282 | 0.560 |
Why?
|
Mercury | 4 | 2022 | 290 | 0.560 |
Why?
|
Pesticide Residues | 4 | 2018 | 95 | 0.550 |
Why?
|
HIV Protease Inhibitors | 6 | 2022 | 432 | 0.530 |
Why?
|
Meningococcal Vaccines | 5 | 2017 | 94 | 0.520 |
Why?
|
Follicle Stimulating Hormone | 9 | 2023 | 724 | 0.520 |
Why?
|
Language Disorders | 2 | 2016 | 139 | 0.500 |
Why?
|
Leiomyoma | 4 | 2021 | 667 | 0.500 |
Why?
|
Fetal Development | 5 | 2023 | 762 | 0.500 |
Why?
|
Halogenated Diphenyl Ethers | 4 | 2024 | 83 | 0.500 |
Why?
|
Infant | 47 | 2024 | 35940 | 0.500 |
Why?
|
Triclosan | 4 | 2019 | 58 | 0.500 |
Why?
|
Epidemiologic Research Design | 1 | 2018 | 367 | 0.490 |
Why?
|
Zidovudine | 6 | 2023 | 624 | 0.490 |
Why?
|
Pregnancy Rate | 11 | 2020 | 650 | 0.480 |
Why?
|
Maternal Age | 6 | 2019 | 806 | 0.460 |
Why?
|
Risk Assessment | 27 | 2021 | 24049 | 0.460 |
Why?
|
Folic Acid | 6 | 2019 | 1303 | 0.460 |
Why?
|
Longitudinal Studies | 32 | 2024 | 14439 | 0.450 |
Why?
|
Anti-Mullerian Hormone | 5 | 2023 | 406 | 0.450 |
Why?
|
Mental Disorders | 11 | 2018 | 6788 | 0.430 |
Why?
|
Bayes Theorem | 14 | 2024 | 2322 | 0.430 |
Why?
|
Preconception Care | 4 | 2019 | 139 | 0.420 |
Why?
|
Prenatal Injuries | 1 | 2012 | 13 | 0.410 |
Why?
|
Stillbirth | 5 | 2023 | 365 | 0.410 |
Why?
|
Infant Mortality | 4 | 2022 | 752 | 0.400 |
Why?
|
Blood Glucose | 9 | 2024 | 6366 | 0.400 |
Why?
|
Diabetes, Gestational | 6 | 2022 | 1241 | 0.400 |
Why?
|
AIDS-Related Opportunistic Infections | 6 | 2015 | 661 | 0.400 |
Why?
|
Pregnancy Trimester, Second | 9 | 2021 | 733 | 0.400 |
Why?
|
Immune Reconstitution Inflammatory Syndrome | 2 | 2009 | 61 | 0.400 |
Why?
|
Benzoxazines | 4 | 2019 | 309 | 0.390 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 5 | 2015 | 85 | 0.390 |
Why?
|
Language Tests | 1 | 2012 | 190 | 0.390 |
Why?
|
Cluster Analysis | 1 | 2018 | 2698 | 0.390 |
Why?
|
Perimenopause | 2 | 2024 | 141 | 0.390 |
Why?
|
Maternal Nutritional Physiological Phenomena | 4 | 2016 | 384 | 0.380 |
Why?
|
Benzophenones | 3 | 2020 | 58 | 0.380 |
Why?
|
Data Interpretation, Statistical | 4 | 2019 | 2694 | 0.370 |
Why?
|
Child, Preschool | 41 | 2023 | 41932 | 0.370 |
Why?
|
Carbanilides | 2 | 2021 | 18 | 0.360 |
Why?
|
Seafood | 4 | 2018 | 390 | 0.360 |
Why?
|
RNA, Viral | 9 | 2015 | 2837 | 0.350 |
Why?
|
Pregnancy Trimesters | 3 | 2023 | 197 | 0.350 |
Why?
|
Meningococcal Infections | 4 | 2017 | 78 | 0.350 |
Why?
|
Infant, Low Birth Weight | 7 | 2023 | 847 | 0.350 |
Why?
|
Government Agencies | 7 | 2002 | 161 | 0.350 |
Why?
|
Risk Factors | 55 | 2021 | 74167 | 0.350 |
Why?
|
Fruit | 5 | 2019 | 1162 | 0.340 |
Why?
|
Vegetables | 5 | 2019 | 1198 | 0.340 |
Why?
|
Preservatives, Pharmaceutical | 3 | 2015 | 34 | 0.340 |
Why?
|
Cross-Sectional Studies | 38 | 2023 | 25853 | 0.340 |
Why?
|
United States | 64 | 2024 | 72238 | 0.330 |
Why?
|
Feeding Behavior | 8 | 2024 | 3183 | 0.330 |
Why?
|
Birth Order | 3 | 2019 | 95 | 0.330 |
Why?
|
Air Pollutants | 7 | 2021 | 2841 | 0.330 |
Why?
|
Massachusetts | 22 | 2020 | 8788 | 0.310 |
Why?
|
Nervous System | 3 | 2018 | 543 | 0.310 |
Why?
|
Medication Adherence | 4 | 2019 | 2161 | 0.310 |
Why?
|
Puerto Rico | 7 | 2019 | 373 | 0.310 |
Why?
|
Plasticizers | 9 | 2019 | 50 | 0.310 |
Why?
|
Oocytes | 5 | 2020 | 1169 | 0.310 |
Why?
|
Trophoblasts | 1 | 2010 | 224 | 0.310 |
Why?
|
Sulfones | 3 | 2021 | 447 | 0.310 |
Why?
|
beta Carotene | 2 | 2019 | 524 | 0.300 |
Why?
|
Spinal Dysraphism | 2 | 2020 | 173 | 0.300 |
Why?
|
Hexachlorobenzene | 4 | 2015 | 27 | 0.300 |
Why?
|
Dairy Products | 3 | 2017 | 495 | 0.300 |
Why?
|
Furans | 5 | 2021 | 198 | 0.300 |
Why?
|
Survival Analysis | 3 | 2017 | 10181 | 0.300 |
Why?
|
Placenta | 3 | 2017 | 1699 | 0.300 |
Why?
|
Alkynes | 4 | 2019 | 313 | 0.300 |
Why?
|
Linear Models | 20 | 2019 | 5876 | 0.290 |
Why?
|
Models, Theoretical | 2 | 2019 | 3556 | 0.290 |
Why?
|
Embryo Implantation | 6 | 2016 | 271 | 0.290 |
Why?
|
Lead Poisoning | 1 | 2010 | 320 | 0.290 |
Why?
|
Substance-Related Disorders | 4 | 2017 | 4358 | 0.290 |
Why?
|
Vaccines, Conjugate | 5 | 2017 | 327 | 0.280 |
Why?
|
Self Report | 11 | 2019 | 3699 | 0.280 |
Why?
|
Cyclopropanes | 4 | 2019 | 430 | 0.280 |
Why?
|
Sexual Behavior | 4 | 2021 | 2086 | 0.280 |
Why?
|
Environmental Monitoring | 11 | 2018 | 1437 | 0.280 |
Why?
|
Eating | 4 | 2018 | 1537 | 0.280 |
Why?
|
Cardiomyopathies | 1 | 2018 | 1939 | 0.270 |
Why?
|
Dietary Supplements | 8 | 2020 | 3388 | 0.270 |
Why?
|
Memory Disorders | 4 | 2017 | 1194 | 0.270 |
Why?
|
Fishes | 4 | 2018 | 600 | 0.270 |
Why?
|
Marijuana Smoking | 2 | 2019 | 253 | 0.260 |
Why?
|
Metals | 4 | 2022 | 730 | 0.260 |
Why?
|
Executive Function | 4 | 2023 | 1366 | 0.260 |
Why?
|
Child Behavior | 3 | 2023 | 848 | 0.260 |
Why?
|
Patient Dropouts | 1 | 2008 | 412 | 0.260 |
Why?
|
Soy Foods | 2 | 2016 | 44 | 0.250 |
Why?
|
Observation | 1 | 2007 | 311 | 0.250 |
Why?
|
Fluorocarbons | 2 | 2020 | 483 | 0.250 |
Why?
|
Boston | 18 | 2024 | 9274 | 0.250 |
Why?
|
Body Mass Index | 16 | 2022 | 12871 | 0.250 |
Why?
|
Triglycerides | 4 | 2022 | 2475 | 0.250 |
Why?
|
Sperm Injections, Intracytoplasmic | 4 | 2019 | 158 | 0.240 |
Why?
|
Cognition Disorders | 6 | 2016 | 3972 | 0.240 |
Why?
|
Diet | 13 | 2019 | 8001 | 0.240 |
Why?
|
Steroids | 1 | 2010 | 927 | 0.240 |
Why?
|
Botswana | 7 | 2023 | 1033 | 0.240 |
Why?
|
Language Development Disorders | 2 | 2018 | 192 | 0.240 |
Why?
|
Pregnancy Complications | 8 | 2020 | 2938 | 0.240 |
Why?
|
Patient Participation | 1 | 2013 | 1437 | 0.230 |
Why?
|
Meat Products | 2 | 2014 | 96 | 0.230 |
Why?
|
Hyperlipidemias | 1 | 2009 | 782 | 0.230 |
Why?
|
Soaps | 2 | 2023 | 29 | 0.220 |
Why?
|
Cognition | 8 | 2020 | 6939 | 0.220 |
Why?
|
Fetal Weight | 1 | 2023 | 87 | 0.220 |
Why?
|
Follicular Fluid | 2 | 2021 | 92 | 0.220 |
Why?
|
Aromatase | 3 | 2017 | 147 | 0.220 |
Why?
|
Caprylates | 2 | 2020 | 108 | 0.220 |
Why?
|
HIV Seropositivity | 4 | 2013 | 955 | 0.220 |
Why?
|
Congenital Abnormalities | 4 | 2024 | 704 | 0.210 |
Why?
|
Drug Therapy, Combination | 11 | 2018 | 6490 | 0.210 |
Why?
|
Mycobacterium avium-intracellulare Infection | 5 | 2003 | 76 | 0.210 |
Why?
|
Delivery, Obstetric | 3 | 2019 | 932 | 0.210 |
Why?
|
Hair | 2 | 2017 | 491 | 0.210 |
Why?
|
Ultrasonography, Prenatal | 2 | 2023 | 1740 | 0.210 |
Why?
|
Age Factors | 16 | 2020 | 18391 | 0.210 |
Why?
|
Dietary Proteins | 2 | 2018 | 947 | 0.210 |
Why?
|
Thyroid Gland | 2 | 2020 | 1169 | 0.210 |
Why?
|
Pharmaceutical Services | 2 | 2019 | 141 | 0.210 |
Why?
|
Vehicle Emissions | 3 | 2018 | 652 | 0.210 |
Why?
|
Particulate Matter | 4 | 2021 | 2557 | 0.200 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 52 | 0.200 |
Why?
|
Hypercholesterolemia | 5 | 2018 | 1155 | 0.200 |
Why?
|
Lamivudine | 3 | 2019 | 363 | 0.200 |
Why?
|
Antibodies, Bacterial | 6 | 2017 | 1469 | 0.200 |
Why?
|
Mothers | 6 | 2021 | 2181 | 0.200 |
Why?
|
Hot Flashes | 2 | 2022 | 327 | 0.200 |
Why?
|
Prevalence | 13 | 2024 | 15639 | 0.190 |
Why?
|
Hearing Loss | 2 | 2023 | 780 | 0.190 |
Why?
|
Patient Selection | 1 | 2013 | 4268 | 0.190 |
Why?
|
HIV Seronegativity | 4 | 2019 | 208 | 0.190 |
Why?
|
Intelligence | 3 | 2014 | 918 | 0.180 |
Why?
|
Adolescent Behavior | 2 | 2021 | 1183 | 0.180 |
Why?
|
Embryo Transfer | 3 | 2020 | 520 | 0.180 |
Why?
|
Cholesterol | 4 | 2022 | 2922 | 0.180 |
Why?
|
Fathers | 2 | 2023 | 371 | 0.180 |
Why?
|
Probability | 3 | 2023 | 2474 | 0.180 |
Why?
|
Mental Health | 2 | 2024 | 3195 | 0.180 |
Why?
|
Cardiovascular Diseases | 8 | 2021 | 15726 | 0.180 |
Why?
|
Anencephaly | 1 | 2020 | 20 | 0.180 |
Why?
|
Logistic Models | 11 | 2019 | 13309 | 0.180 |
Why?
|
Waist Circumference | 3 | 2022 | 921 | 0.180 |
Why?
|
Coronary Disease | 3 | 2019 | 5989 | 0.180 |
Why?
|
Fluoxetine | 1 | 2004 | 733 | 0.180 |
Why?
|
Arsenic | 2 | 2022 | 343 | 0.180 |
Why?
|
Didanosine | 1 | 2020 | 151 | 0.180 |
Why?
|
Menarche | 1 | 2023 | 529 | 0.180 |
Why?
|
Occupational Exposure | 5 | 2017 | 1806 | 0.180 |
Why?
|
Oxazines | 1 | 2022 | 340 | 0.180 |
Why?
|
Severity of Illness Index | 13 | 2018 | 15815 | 0.180 |
Why?
|
Body Composition | 2 | 2019 | 2414 | 0.170 |
Why?
|
Middle Aged | 56 | 2024 | 219628 | 0.170 |
Why?
|
Postpartum Period | 3 | 2024 | 1167 | 0.170 |
Why?
|
Serologic Tests | 2 | 2022 | 383 | 0.170 |
Why?
|
Proportional Hazards Models | 13 | 2021 | 12526 | 0.170 |
Why?
|
Michigan | 4 | 2021 | 340 | 0.170 |
Why?
|
Patient Compliance | 2 | 2008 | 2689 | 0.170 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2022 | 273 | 0.170 |
Why?
|
Infant, Small for Gestational Age | 4 | 2017 | 454 | 0.170 |
Why?
|
Sample Size | 1 | 2023 | 839 | 0.170 |
Why?
|
Luteinizing Hormone | 1 | 2022 | 820 | 0.170 |
Why?
|
Oocyte Retrieval | 2 | 2020 | 159 | 0.170 |
Why?
|
BCG Vaccine | 1 | 2022 | 370 | 0.170 |
Why?
|
Carnitine | 2 | 2022 | 252 | 0.170 |
Why?
|
Body Height | 6 | 2017 | 1569 | 0.160 |
Why?
|
Household Products | 1 | 2019 | 27 | 0.160 |
Why?
|
Condoms | 1 | 2021 | 315 | 0.160 |
Why?
|
Diet Surveys | 6 | 2019 | 1160 | 0.160 |
Why?
|
Infant, Newborn, Diseases | 1 | 2004 | 592 | 0.160 |
Why?
|
Birth Intervals | 1 | 2018 | 51 | 0.160 |
Why?
|
Fertility Agents | 1 | 2018 | 11 | 0.160 |
Why?
|
Electromagnetic Fields | 1 | 2020 | 296 | 0.160 |
Why?
|
Thyrotropin | 2 | 2020 | 832 | 0.160 |
Why?
|
Exercise | 3 | 2021 | 5774 | 0.160 |
Why?
|
Viremia | 2 | 2022 | 708 | 0.160 |
Why?
|
Sunscreening Agents | 1 | 2019 | 139 | 0.160 |
Why?
|
Cardiovascular Abnormalities | 1 | 2019 | 143 | 0.160 |
Why?
|
Cleavage Stage, Ovum | 1 | 2018 | 44 | 0.160 |
Why?
|
Body Size | 2 | 2012 | 461 | 0.150 |
Why?
|
Ozone | 2 | 2020 | 477 | 0.150 |
Why?
|
DEET | 1 | 2017 | 10 | 0.150 |
Why?
|
Diet, Mediterranean | 3 | 2020 | 732 | 0.150 |
Why?
|
Trace Elements | 1 | 2019 | 196 | 0.150 |
Why?
|
Follow-Up Studies | 19 | 2021 | 39213 | 0.150 |
Why?
|
Treatment Outcome | 25 | 2022 | 64867 | 0.150 |
Why?
|
Estradiol | 5 | 2024 | 1931 | 0.150 |
Why?
|
Clothing | 1 | 2018 | 97 | 0.150 |
Why?
|
Amiloride | 1 | 2017 | 116 | 0.150 |
Why?
|
Causality | 4 | 2022 | 1240 | 0.150 |
Why?
|
Muscular Diseases | 1 | 2022 | 550 | 0.150 |
Why?
|
Embryo Culture Techniques | 1 | 2018 | 82 | 0.150 |
Why?
|
Noise | 1 | 2020 | 278 | 0.150 |
Why?
|
Pyrethrins | 1 | 2017 | 44 | 0.150 |
Why?
|
Incidence | 18 | 2021 | 21344 | 0.150 |
Why?
|
Ventricular Function, Left | 3 | 2016 | 3854 | 0.150 |
Why?
|
Minerals | 1 | 2019 | 282 | 0.150 |
Why?
|
Glucose Intolerance | 1 | 2022 | 579 | 0.150 |
Why?
|
Reproductive Medicine | 1 | 2019 | 100 | 0.150 |
Why?
|
Reproductive History | 1 | 2018 | 210 | 0.150 |
Why?
|
Product Packaging | 1 | 2017 | 24 | 0.140 |
Why?
|
Air Pollution | 3 | 2020 | 2318 | 0.140 |
Why?
|
Pregnancy, Ectopic | 1 | 2018 | 144 | 0.140 |
Why?
|
Adenine | 2 | 2013 | 976 | 0.140 |
Why?
|
Ovulation Induction | 5 | 2019 | 275 | 0.140 |
Why?
|
Pyridones | 1 | 2022 | 787 | 0.140 |
Why?
|
Infant Formula | 1 | 2018 | 193 | 0.140 |
Why?
|
Parity | 4 | 2021 | 925 | 0.140 |
Why?
|
Pre-Eclampsia | 2 | 2019 | 1230 | 0.140 |
Why?
|
Copper | 1 | 2019 | 367 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 517 | 0.140 |
Why?
|
Micronutrients | 1 | 2020 | 380 | 0.140 |
Why?
|
Sperm-Ovum Interactions | 1 | 2016 | 23 | 0.140 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2018 | 363 | 0.140 |
Why?
|
Ovary | 3 | 2023 | 961 | 0.140 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2016 | 40 | 0.140 |
Why?
|
Odds Ratio | 12 | 2019 | 9712 | 0.140 |
Why?
|
Lifting | 1 | 2017 | 54 | 0.140 |
Why?
|
Nervous System Diseases | 2 | 2020 | 1645 | 0.140 |
Why?
|
Echocardiography | 6 | 2019 | 4970 | 0.140 |
Why?
|
Neuropsychological Tests | 9 | 2017 | 7003 | 0.140 |
Why?
|
Gels | 1 | 2017 | 419 | 0.130 |
Why?
|
Dicarboxylic Acids | 1 | 2016 | 77 | 0.130 |
Why?
|
Spouses | 1 | 2018 | 279 | 0.130 |
Why?
|
Ascorbic Acid | 1 | 2019 | 655 | 0.130 |
Why?
|
Cytomegalovirus Infections | 2 | 2019 | 831 | 0.130 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2018 | 6016 | 0.130 |
Why?
|
Inflammation | 4 | 2023 | 10746 | 0.130 |
Why?
|
Drug Synergism | 2 | 2018 | 1752 | 0.130 |
Why?
|
Socioeconomic Factors | 6 | 2015 | 7790 | 0.130 |
Why?
|
Fetus | 2 | 2020 | 1862 | 0.130 |
Why?
|
Sex Factors | 8 | 2022 | 10515 | 0.130 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2016 | 140 | 0.130 |
Why?
|
Obesity, Abdominal | 1 | 2019 | 375 | 0.130 |
Why?
|
Testosterone | 4 | 2024 | 2468 | 0.130 |
Why?
|
Calcifediol | 1 | 2016 | 160 | 0.130 |
Why?
|
Hypolipidemic Agents | 2 | 2011 | 626 | 0.130 |
Why?
|
Fuel Oils | 2 | 2005 | 35 | 0.130 |
Why?
|
Growth | 2 | 2010 | 365 | 0.130 |
Why?
|
Urine | 2 | 2015 | 363 | 0.130 |
Why?
|
Twins | 2 | 2009 | 339 | 0.130 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2015 | 52 | 0.130 |
Why?
|
Electric Impedance | 1 | 2019 | 749 | 0.130 |
Why?
|
Cholesterol, HDL | 2 | 2019 | 1816 | 0.130 |
Why?
|
Meconium | 1 | 2015 | 47 | 0.130 |
Why?
|
Radio Waves | 1 | 2016 | 250 | 0.120 |
Why?
|
Insulin Resistance | 3 | 2019 | 3959 | 0.120 |
Why?
|
Blastocyst | 1 | 2018 | 427 | 0.120 |
Why?
|
Testis | 1 | 2018 | 794 | 0.120 |
Why?
|
Speech Perception | 1 | 2020 | 505 | 0.120 |
Why?
|
C-Reactive Protein | 6 | 2023 | 3822 | 0.120 |
Why?
|
Immunization, Secondary | 1 | 2017 | 366 | 0.120 |
Why?
|
Medicaid | 5 | 2015 | 2808 | 0.120 |
Why?
|
Georgia | 1 | 2015 | 185 | 0.120 |
Why?
|
Computer Simulation | 2 | 2018 | 6195 | 0.120 |
Why?
|
Functional Food | 1 | 2014 | 20 | 0.120 |
Why?
|
Polymorphism, Genetic | 3 | 2013 | 4283 | 0.120 |
Why?
|
Otoacoustic Emissions, Spontaneous | 1 | 2015 | 139 | 0.120 |
Why?
|
Antioxidants | 2 | 2019 | 1666 | 0.120 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 53 | 0.120 |
Why?
|
Fetal Diseases | 1 | 2020 | 910 | 0.120 |
Why?
|
Diphtheria Toxoid | 2 | 2012 | 26 | 0.120 |
Why?
|
Periodontitis | 3 | 2011 | 565 | 0.110 |
Why?
|
Language Development | 1 | 2015 | 180 | 0.110 |
Why?
|
Norway | 3 | 2020 | 497 | 0.110 |
Why?
|
Prenatal Care | 2 | 2019 | 1125 | 0.110 |
Why?
|
Autoimmunity | 2 | 2020 | 1358 | 0.110 |
Why?
|
Gestational Age | 7 | 2021 | 3558 | 0.110 |
Why?
|
Drug Combinations | 1 | 2019 | 2021 | 0.110 |
Why?
|
Quality of Life | 5 | 2023 | 13285 | 0.110 |
Why?
|
Refusal to Participate | 1 | 2013 | 31 | 0.110 |
Why?
|
Psychometrics | 3 | 2018 | 3046 | 0.110 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2020 | 781 | 0.110 |
Why?
|
Benzofurans | 2 | 2011 | 142 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2016 | 2128 | 0.110 |
Why?
|
Embryonic Development | 1 | 2018 | 713 | 0.110 |
Why?
|
AIDS Dementia Complex | 2 | 2015 | 153 | 0.110 |
Why?
|
Autoantibodies | 2 | 2018 | 2114 | 0.110 |
Why?
|
Granulosa Cells | 1 | 2013 | 117 | 0.110 |
Why?
|
Guideline Adherence | 2 | 2019 | 2283 | 0.110 |
Why?
|
Lymphopenia | 1 | 2015 | 280 | 0.110 |
Why?
|
Menopause | 1 | 2021 | 1640 | 0.110 |
Why?
|
Tanzania | 3 | 2022 | 1374 | 0.110 |
Why?
|
Behavior | 1 | 2016 | 539 | 0.110 |
Why?
|
Food Preservatives | 1 | 2012 | 11 | 0.100 |
Why?
|
Work Schedule Tolerance | 1 | 2017 | 551 | 0.100 |
Why?
|
Dideoxynucleosides | 1 | 2013 | 132 | 0.100 |
Why?
|
Epidemiologic Methods | 4 | 2013 | 1341 | 0.100 |
Why?
|
Drug Utilization | 3 | 2014 | 1195 | 0.100 |
Why?
|
Air Pollutants, Occupational | 2 | 2005 | 407 | 0.100 |
Why?
|
Dibutyl Phthalate | 2 | 2022 | 29 | 0.100 |
Why?
|
Antidepressive Agents | 3 | 2013 | 2888 | 0.100 |
Why?
|
Child of Impaired Parents | 2 | 2013 | 459 | 0.100 |
Why?
|
Vitamin B 12 | 1 | 2015 | 522 | 0.100 |
Why?
|
Head | 1 | 2018 | 921 | 0.100 |
Why?
|
Meat | 1 | 2015 | 584 | 0.100 |
Why?
|
Uterine Neoplasms | 1 | 2021 | 1442 | 0.100 |
Why?
|
Life Style | 3 | 2019 | 3886 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 4 | 2022 | 1181 | 0.100 |
Why?
|
Time Factors | 11 | 2020 | 40083 | 0.100 |
Why?
|
Obesity | 6 | 2024 | 12896 | 0.100 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2014 | 388 | 0.100 |
Why?
|
Piperazines | 1 | 2022 | 2516 | 0.100 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2021 | 1387 | 0.100 |
Why?
|
Caffeine | 1 | 2016 | 701 | 0.100 |
Why?
|
Sex Chromosome Aberrations | 1 | 2011 | 116 | 0.100 |
Why?
|
Brain | 5 | 2023 | 26860 | 0.100 |
Why?
|
Gonadal Steroid Hormones | 3 | 2024 | 700 | 0.100 |
Why?
|
Toll-Like Receptor 9 | 1 | 2013 | 234 | 0.100 |
Why?
|
Multivariate Analysis | 9 | 2019 | 12152 | 0.100 |
Why?
|
Sexually Transmitted Diseases | 1 | 2017 | 627 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2019 | 4299 | 0.100 |
Why?
|
Case-Control Studies | 13 | 2020 | 21992 | 0.100 |
Why?
|
Liver Failure | 1 | 2013 | 248 | 0.100 |
Why?
|
Cytokines | 2 | 2024 | 7290 | 0.100 |
Why?
|
PPAR gamma | 2 | 2017 | 484 | 0.100 |
Why?
|
Women's Health | 4 | 2024 | 2057 | 0.090 |
Why?
|
Glucose | 2 | 2021 | 4362 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2018 | 2649 | 0.090 |
Why?
|
Inhalation Exposure | 2 | 2005 | 429 | 0.090 |
Why?
|
Central Nervous System Stimulants | 3 | 2016 | 1169 | 0.090 |
Why?
|
Air Pollution, Indoor | 2 | 2013 | 890 | 0.090 |
Why?
|
No-Observed-Adverse-Effect Level | 7 | 2002 | 25 | 0.090 |
Why?
|
Dietary Carbohydrates | 1 | 2016 | 893 | 0.090 |
Why?
|
Toll-Like Receptor 2 | 1 | 2013 | 348 | 0.090 |
Why?
|
Chromosomes, Human, Y | 1 | 2011 | 162 | 0.090 |
Why?
|
Breast Feeding | 4 | 2023 | 1357 | 0.090 |
Why?
|
Nucleosides | 1 | 2011 | 131 | 0.090 |
Why?
|
Insulin | 2 | 2023 | 6589 | 0.090 |
Why?
|
Cleft Lip | 2 | 2007 | 504 | 0.090 |
Why?
|
Periodontal Diseases | 2 | 2004 | 451 | 0.090 |
Why?
|
Regression Analysis | 7 | 2017 | 6358 | 0.090 |
Why?
|
Neisseria meningitidis, Serogroup Y | 3 | 2017 | 3 | 0.090 |
Why?
|
Neisseria meningitidis, Serogroup W-135 | 3 | 2017 | 3 | 0.090 |
Why?
|
Cleft Palate | 2 | 2007 | 587 | 0.090 |
Why?
|
Neisseria meningitidis, Serogroup A | 3 | 2017 | 6 | 0.090 |
Why?
|
Neisseria meningitidis, Serogroup C | 3 | 2017 | 11 | 0.090 |
Why?
|
Receptors, IgG | 1 | 2013 | 566 | 0.090 |
Why?
|
Postpartum Hemorrhage | 1 | 2013 | 265 | 0.090 |
Why?
|
Peer Group | 2 | 2012 | 670 | 0.090 |
Why?
|
Dietary Fats | 2 | 2016 | 1992 | 0.080 |
Why?
|
Oligopeptides | 1 | 2015 | 1186 | 0.080 |
Why?
|
Wechsler Scales | 3 | 2015 | 256 | 0.080 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2009 | 33 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2013 | 580 | 0.080 |
Why?
|
Pregnancy Trimester, Third | 3 | 2020 | 582 | 0.080 |
Why?
|
Tooth Diseases | 1 | 2009 | 74 | 0.080 |
Why?
|
Caregivers | 3 | 2017 | 2213 | 0.080 |
Why?
|
Residence Characteristics | 2 | 2018 | 2035 | 0.080 |
Why?
|
Myocardial Infarction | 4 | 2019 | 11891 | 0.080 |
Why?
|
Vanadium | 2 | 2005 | 54 | 0.080 |
Why?
|
Alcohol-Related Disorders | 1 | 2011 | 235 | 0.080 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2013 | 450 | 0.080 |
Why?
|
Alveolar Bone Loss | 3 | 2008 | 388 | 0.080 |
Why?
|
Occupational Diseases | 1 | 2017 | 1484 | 0.080 |
Why?
|
Ritonavir | 2 | 2022 | 328 | 0.080 |
Why?
|
Mycobacterium avium Complex | 3 | 2003 | 60 | 0.080 |
Why?
|
Bone and Bones | 1 | 2019 | 2558 | 0.080 |
Why?
|
Cattle | 1 | 2014 | 3844 | 0.080 |
Why?
|
Government Programs | 7 | 2002 | 280 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2015 | 1550 | 0.080 |
Why?
|
Progesterone | 2 | 2024 | 743 | 0.080 |
Why?
|
Aneuploidy | 1 | 2011 | 551 | 0.080 |
Why?
|
Welding | 2 | 2005 | 89 | 0.080 |
Why?
|
Epidemiologic Studies | 2 | 2018 | 669 | 0.080 |
Why?
|
Herpesvirus 3, Human | 1 | 2009 | 159 | 0.070 |
Why?
|
Body Weights and Measures | 1 | 2008 | 208 | 0.070 |
Why?
|
Dental Care | 1 | 2011 | 278 | 0.070 |
Why?
|
South Africa | 2 | 2023 | 1810 | 0.070 |
Why?
|
Memory | 1 | 2017 | 2179 | 0.070 |
Why?
|
Psychotropic Drugs | 2 | 2012 | 882 | 0.070 |
Why?
|
Body Fat Distribution | 1 | 2009 | 243 | 0.070 |
Why?
|
Power Plants | 2 | 2005 | 124 | 0.070 |
Why?
|
Liver Diseases | 1 | 2016 | 1296 | 0.070 |
Why?
|
Diseases in Twins | 1 | 2009 | 447 | 0.070 |
Why?
|
Hypertension | 3 | 2022 | 8582 | 0.070 |
Why?
|
Nutrition Assessment | 3 | 2015 | 725 | 0.070 |
Why?
|
Mouth Diseases | 1 | 2009 | 238 | 0.070 |
Why?
|
Cholesterol, LDL | 3 | 2019 | 2417 | 0.070 |
Why?
|
Body Weight | 6 | 2017 | 4606 | 0.070 |
Why?
|
Arsenic Poisoning | 1 | 2007 | 54 | 0.070 |
Why?
|
Registries | 6 | 2020 | 8435 | 0.070 |
Why?
|
Glutathione S-Transferase pi | 1 | 2007 | 100 | 0.070 |
Why?
|
Diet Records | 2 | 2020 | 427 | 0.070 |
Why?
|
Mood Disorders | 1 | 2013 | 1123 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1379 | 0.070 |
Why?
|
Birth Rate | 2 | 2019 | 167 | 0.070 |
Why?
|
Oxygen | 1 | 2018 | 4188 | 0.070 |
Why?
|
Obstetric Labor Complications | 1 | 2009 | 236 | 0.070 |
Why?
|
Anxiety Disorders | 2 | 2018 | 2709 | 0.070 |
Why?
|
Maxillary Diseases | 1 | 2006 | 48 | 0.070 |
Why?
|
Lactic Acid | 1 | 2011 | 1132 | 0.070 |
Why?
|
Affective Symptoms | 1 | 2009 | 416 | 0.070 |
Why?
|
Research Design | 3 | 2024 | 6165 | 0.070 |
Why?
|
Herpes Zoster | 1 | 2009 | 250 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1673 | 0.070 |
Why?
|
Bone Density | 1 | 2019 | 3517 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2017 | 12765 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1882 | 0.070 |
Why?
|
Fertilization | 2 | 2018 | 198 | 0.070 |
Why?
|
Comorbidity | 3 | 2022 | 10550 | 0.070 |
Why?
|
Resuscitation Orders | 1 | 2008 | 270 | 0.060 |
Why?
|
Mannose-Binding Lectin | 1 | 2007 | 146 | 0.060 |
Why?
|
Spermatogenesis | 2 | 2019 | 257 | 0.060 |
Why?
|
Confidence Intervals | 4 | 2014 | 2932 | 0.060 |
Why?
|
Labor, Obstetric | 1 | 2009 | 321 | 0.060 |
Why?
|
Serum Bactericidal Antibody Assay | 2 | 2017 | 2 | 0.060 |
Why?
|
Adaptation, Psychological | 2 | 2016 | 2627 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2010 | 7593 | 0.060 |
Why?
|
Mandibular Diseases | 1 | 2006 | 119 | 0.060 |
Why?
|
Public Health | 1 | 2018 | 2656 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3152 | 0.060 |
Why?
|
Pilot Projects | 4 | 2023 | 8530 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 1919 | 0.060 |
Why?
|
Chromatography, Liquid | 2 | 2022 | 983 | 0.060 |
Why?
|
Chemical Industry | 1 | 2005 | 115 | 0.060 |
Why?
|
Weight Gain | 3 | 2022 | 2345 | 0.060 |
Why?
|
Endometrium | 2 | 2019 | 404 | 0.060 |
Why?
|
Risk-Taking | 1 | 2010 | 999 | 0.060 |
Why?
|
Glutathione Transferase | 1 | 2007 | 565 | 0.060 |
Why?
|
Beverages | 2 | 2022 | 819 | 0.060 |
Why?
|
Heart Ventricles | 1 | 2016 | 3802 | 0.060 |
Why?
|
Animals | 19 | 2022 | 167531 | 0.060 |
Why?
|
DNA Methylation | 1 | 2018 | 4371 | 0.060 |
Why?
|
Ethambutol | 1 | 2003 | 59 | 0.060 |
Why?
|
Rifabutin | 1 | 2003 | 58 | 0.060 |
Why?
|
Behavior Therapy | 1 | 2009 | 870 | 0.060 |
Why?
|
Clarithromycin | 1 | 2003 | 85 | 0.050 |
Why?
|
Hepatitis C | 1 | 2013 | 1580 | 0.050 |
Why?
|
Poisson Distribution | 2 | 2017 | 507 | 0.050 |
Why?
|
Attitude to Health | 1 | 2012 | 2028 | 0.050 |
Why?
|
Pyridines | 1 | 2015 | 2876 | 0.050 |
Why?
|
Procarbazine | 1 | 2022 | 172 | 0.050 |
Why?
|
Androgen Antagonists | 2 | 2022 | 1443 | 0.050 |
Why?
|
Lymphocyte Count | 2 | 2019 | 776 | 0.050 |
Why?
|
Gasoline | 1 | 2022 | 53 | 0.050 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2003 | 190 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2011 | 1208 | 0.050 |
Why?
|
Vaccination | 3 | 2022 | 3354 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 24 | 0.050 |
Why?
|
New York | 2 | 2016 | 874 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2018 | 3693 | 0.050 |
Why?
|
Educational Status | 3 | 2014 | 2512 | 0.050 |
Why?
|
Analysis of Variance | 4 | 2014 | 6239 | 0.050 |
Why?
|
Health Surveys | 2 | 2010 | 4059 | 0.050 |
Why?
|
Academic Medical Centers | 3 | 2019 | 2750 | 0.050 |
Why?
|
Nitrogen Dioxide | 2 | 2020 | 512 | 0.050 |
Why?
|
Teratogens | 1 | 2002 | 117 | 0.050 |
Why?
|
Nutrition Surveys | 2 | 2019 | 1722 | 0.050 |
Why?
|
Drug Administration Schedule | 3 | 2018 | 4893 | 0.050 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14648 | 0.050 |
Why?
|
Pharmacoepidemiology | 1 | 2005 | 346 | 0.050 |
Why?
|
Receptors, CCR | 1 | 2021 | 37 | 0.050 |
Why?
|
Overweight | 2 | 2023 | 2420 | 0.050 |
Why?
|
Beta Particles | 1 | 2021 | 47 | 0.050 |
Why?
|
Brain Mapping | 1 | 2016 | 6559 | 0.050 |
Why?
|
Cadmium | 1 | 2022 | 215 | 0.050 |
Why?
|
Population Surveillance | 3 | 2020 | 2610 | 0.050 |
Why?
|
Phenol | 1 | 2021 | 44 | 0.050 |
Why?
|
Perinatal Care | 2 | 2014 | 240 | 0.050 |
Why?
|
Ghana | 1 | 2022 | 311 | 0.050 |
Why?
|
Prostaglandins | 1 | 2022 | 398 | 0.050 |
Why?
|
Glucose Tolerance Test | 1 | 2024 | 1174 | 0.050 |
Why?
|
Time | 2 | 2016 | 545 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20027 | 0.050 |
Why?
|
Troponin T | 2 | 2018 | 774 | 0.050 |
Why?
|
Hospice Care | 1 | 2008 | 693 | 0.050 |
Why?
|
Ambulatory Care Facilities | 2 | 2017 | 924 | 0.050 |
Why?
|
Family Characteristics | 2 | 2016 | 1001 | 0.050 |
Why?
|
Heart Rate | 2 | 2002 | 4165 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2023 | 36164 | 0.050 |
Why?
|
Intelligence Tests | 2 | 2014 | 498 | 0.050 |
Why?
|
Safe Sex | 1 | 2021 | 138 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6070 | 0.040 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7460 | 0.040 |
Why?
|
14-3-3 Proteins | 1 | 2021 | 221 | 0.040 |
Why?
|
Quinolinic Acid | 1 | 2020 | 67 | 0.040 |
Why?
|
Erythrocyte Transfusion | 1 | 2005 | 564 | 0.040 |
Why?
|
Organ Size | 2 | 2017 | 2247 | 0.040 |
Why?
|
Microbial Viability | 2 | 2012 | 237 | 0.040 |
Why?
|
Pain Measurement | 1 | 2010 | 3511 | 0.040 |
Why?
|
Molybdenum | 1 | 2019 | 45 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2022 | 290 | 0.040 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 81 | 0.040 |
Why?
|
Statistics as Topic | 2 | 2005 | 2364 | 0.040 |
Why?
|
Particle Size | 4 | 2005 | 1638 | 0.040 |
Why?
|
Interleukin-6 | 2 | 2023 | 3201 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2005 | 3329 | 0.040 |
Why?
|
Antipsychotic Agents | 2 | 2009 | 3060 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 12270 | 0.040 |
Why?
|
Uganda | 1 | 2024 | 1326 | 0.040 |
Why?
|
Hearing | 1 | 2023 | 499 | 0.040 |
Why?
|
Cause of Death | 1 | 2010 | 3719 | 0.040 |
Why?
|
Vitamin A | 1 | 2022 | 613 | 0.040 |
Why?
|
Quinolones | 1 | 2022 | 376 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2022 | 754 | 0.040 |
Why?
|
Body Burden | 1 | 2019 | 158 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10825 | 0.040 |
Why?
|
Self Concept | 2 | 2018 | 1037 | 0.040 |
Why?
|
Sweden | 3 | 2009 | 1381 | 0.040 |
Why?
|
Anthropometry | 2 | 2019 | 1344 | 0.040 |
Why?
|
Personality Assessment | 2 | 2012 | 650 | 0.040 |
Why?
|
Iodide Peroxidase | 1 | 2020 | 294 | 0.040 |
Why?
|
Demography | 2 | 2018 | 1648 | 0.040 |
Why?
|
Sterilization, Tubal | 1 | 2018 | 80 | 0.040 |
Why?
|
Disease Progression | 2 | 2016 | 13470 | 0.040 |
Why?
|
Women | 1 | 2020 | 224 | 0.040 |
Why?
|
Thyroglobulin | 1 | 2018 | 111 | 0.040 |
Why?
|
Insect Repellents | 1 | 2017 | 17 | 0.040 |
Why?
|
Selection Bias | 1 | 2020 | 358 | 0.040 |
Why?
|
Chlamydiaceae Infections | 1 | 2017 | 2 | 0.040 |
Why?
|
Parturition | 1 | 2022 | 445 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4423 | 0.040 |
Why?
|
Alkanesulfonic Acids | 1 | 2020 | 199 | 0.040 |
Why?
|
Algorithms | 3 | 2019 | 13951 | 0.040 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1999 | 245 | 0.040 |
Why?
|
Estradiol Dehydrogenases | 1 | 2017 | 15 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 290 | 0.040 |
Why?
|
Puerperal Disorders | 1 | 2020 | 300 | 0.040 |
Why?
|
Infant, Premature | 2 | 2020 | 2085 | 0.040 |
Why?
|
Mitochondria | 1 | 2011 | 3599 | 0.040 |
Why?
|
Cholesterol Side-Chain Cleavage Enzyme | 1 | 2017 | 27 | 0.040 |
Why?
|
Fatty Acid Transport Proteins | 1 | 2017 | 31 | 0.040 |
Why?
|
New England | 1 | 2020 | 1042 | 0.040 |
Why?
|
Fetal Blood | 1 | 2024 | 1339 | 0.040 |
Why?
|
Intrauterine Devices | 1 | 2018 | 113 | 0.040 |
Why?
|
Thyroid Hormones | 1 | 2020 | 403 | 0.040 |
Why?
|
Pharmacies | 1 | 2019 | 164 | 0.040 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 2017 | 95 | 0.040 |
Why?
|
Nutritive Value | 1 | 2020 | 349 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2018 | 1705 | 0.040 |
Why?
|
Polypropylenes | 1 | 2017 | 63 | 0.040 |
Why?
|
Kenya | 1 | 2019 | 749 | 0.040 |
Why?
|
Serum | 1 | 2018 | 212 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2002 | 697 | 0.040 |
Why?
|
Glass | 1 | 2017 | 115 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2002 | 640 | 0.030 |
Why?
|
Cities | 1 | 2019 | 538 | 0.030 |
Why?
|
Plastics | 1 | 2017 | 115 | 0.030 |
Why?
|
Triiodothyronine | 1 | 2018 | 493 | 0.030 |
Why?
|
Alcohol Drinking | 3 | 2019 | 4006 | 0.030 |
Why?
|
Selenium | 1 | 2019 | 416 | 0.030 |
Why?
|
Stroke | 1 | 2019 | 9936 | 0.030 |
Why?
|
Gene Expression | 3 | 2017 | 7583 | 0.030 |
Why?
|
Inflammasomes | 1 | 2021 | 531 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2022 | 2225 | 0.030 |
Why?
|
Culture Media | 1 | 2018 | 899 | 0.030 |
Why?
|
Phytoestrogens | 1 | 2016 | 59 | 0.030 |
Why?
|
Pregnant Women | 1 | 2020 | 563 | 0.030 |
Why?
|
Ecosystem | 1 | 2020 | 488 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 696 | 0.030 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2018 | 545 | 0.030 |
Why?
|
Phosphates | 1 | 2019 | 770 | 0.030 |
Why?
|
Poultry | 1 | 2015 | 81 | 0.030 |
Why?
|
Insemination, Artificial, Homologous | 1 | 2015 | 17 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1886 | 0.030 |
Why?
|
Indoles | 1 | 2003 | 1828 | 0.030 |
Why?
|
Pectinidae | 1 | 2015 | 5 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2018 | 1702 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 784 | 0.030 |
Why?
|
Zinc | 1 | 2019 | 688 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2023 | 80125 | 0.030 |
Why?
|
Carbonated Beverages | 1 | 2016 | 209 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2019 | 757 | 0.030 |
Why?
|
Premenopause | 1 | 2019 | 1039 | 0.030 |
Why?
|
Food Handling | 1 | 2015 | 155 | 0.030 |
Why?
|
Sexual Partners | 1 | 2019 | 749 | 0.030 |
Why?
|
Pain | 1 | 2010 | 5059 | 0.030 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2017 | 214 | 0.030 |
Why?
|
Tea | 1 | 2016 | 283 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 938 | 0.030 |
Why?
|
Caribbean Region | 1 | 2015 | 191 | 0.030 |
Why?
|
Androstanes | 1 | 2014 | 20 | 0.030 |
Why?
|
Thyroxine | 1 | 2018 | 667 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2019 | 1807 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2016 | 415 | 0.030 |
Why?
|
Tennessee | 1 | 2014 | 119 | 0.030 |
Why?
|
Shellfish | 1 | 2014 | 37 | 0.030 |
Why?
|
Radiography | 3 | 2015 | 6964 | 0.030 |
Why?
|
Gonadotropins | 1 | 2015 | 242 | 0.030 |
Why?
|
Rats | 7 | 2002 | 23577 | 0.030 |
Why?
|
Seasons | 1 | 2020 | 1523 | 0.030 |
Why?
|
Protein Precursors | 1 | 2018 | 1135 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 987 | 0.030 |
Why?
|
District of Columbia | 1 | 2014 | 160 | 0.030 |
Why?
|
Latin America | 1 | 2015 | 404 | 0.030 |
Why?
|
Aging | 3 | 2021 | 8633 | 0.030 |
Why?
|
Depression | 1 | 2013 | 8026 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2393 | 0.030 |
Why?
|
Spectrophotometry, Atomic | 1 | 2013 | 81 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2019 | 1725 | 0.030 |
Why?
|
Urinalysis | 1 | 2015 | 368 | 0.030 |
Why?
|
Speech | 1 | 2018 | 547 | 0.030 |
Why?
|
Platelet Count | 1 | 2016 | 776 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2019 | 867 | 0.030 |
Why?
|
Meningitis, Meningococcal | 1 | 2013 | 44 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2124 | 0.030 |
Why?
|
Smoking | 2 | 2013 | 9066 | 0.030 |
Why?
|
Palliative Care | 1 | 2008 | 3608 | 0.030 |
Why?
|
Luminescence | 1 | 2013 | 132 | 0.030 |
Why?
|
Microglia | 1 | 2021 | 1347 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2015 | 597 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2019 | 1792 | 0.030 |
Why?
|
Reference Values | 2 | 2014 | 4914 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2020 | 1260 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 559 | 0.030 |
Why?
|
Anxiety, Separation | 1 | 2012 | 86 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2010 | 11461 | 0.030 |
Why?
|
Urban Health | 1 | 2015 | 533 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2018 | 1665 | 0.030 |
Why?
|
Oral Health | 2 | 2011 | 484 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5875 | 0.030 |
Why?
|
Neisseria meningitidis | 1 | 2012 | 106 | 0.020 |
Why?
|
Coffee | 1 | 2016 | 582 | 0.020 |
Why?
|
Ultrasonography | 2 | 2017 | 5954 | 0.020 |
Why?
|
DDT | 1 | 2011 | 31 | 0.020 |
Why?
|
Nutritional Status | 1 | 2020 | 1604 | 0.020 |
Why?
|
Hot Temperature | 1 | 2018 | 1434 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 2017 | 1155 | 0.020 |
Why?
|
Audiometry | 1 | 2012 | 253 | 0.020 |
Why?
|
Emotions | 1 | 2023 | 2731 | 0.020 |
Why?
|
Fibrinogen | 1 | 2015 | 886 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2014 | 330 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1620 | 0.020 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2013 | 432 | 0.020 |
Why?
|
Meiosis | 1 | 2013 | 327 | 0.020 |
Why?
|
Serotyping | 1 | 2012 | 324 | 0.020 |
Why?
|
Hospitals, General | 1 | 2015 | 795 | 0.020 |
Why?
|
Medical Records | 1 | 2017 | 1405 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2023 | 1939 | 0.020 |
Why?
|
Papillomavirus Vaccines | 1 | 2017 | 484 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2891 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2013 | 377 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2867 | 0.020 |
Why?
|
NADH Dehydrogenase | 1 | 2011 | 46 | 0.020 |
Why?
|
Geography | 1 | 2013 | 661 | 0.020 |
Why?
|
Databases, Factual | 2 | 2019 | 8001 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2003 | 3062 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4772 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2022 | 3105 | 0.020 |
Why?
|
Workload | 1 | 2017 | 842 | 0.020 |
Why?
|
Receptors, Glucocorticoid | 1 | 2012 | 296 | 0.020 |
Why?
|
Periodontal Attachment Loss | 1 | 2011 | 144 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2017 | 1339 | 0.020 |
Why?
|
Periodontal Pocket | 1 | 2011 | 167 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1972 | 0.020 |
Why?
|
Electron Transport Complex IV | 1 | 2011 | 190 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2011 | 352 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1848 | 0.020 |
Why?
|
Milk | 1 | 2013 | 443 | 0.020 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2012 | 306 | 0.020 |
Why?
|
Prognosis | 1 | 2011 | 29559 | 0.020 |
Why?
|
Chromosomes | 1 | 2013 | 576 | 0.020 |
Why?
|
Aged | 8 | 2021 | 168615 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 436 | 0.020 |
Why?
|
Education, Special | 1 | 2010 | 86 | 0.020 |
Why?
|
Cyclophilins | 1 | 2009 | 47 | 0.020 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2009 | 57 | 0.020 |
Why?
|
Breech Presentation | 1 | 2009 | 39 | 0.020 |
Why?
|
Decision Trees | 1 | 2011 | 506 | 0.020 |
Why?
|
Urban Population | 1 | 2017 | 2015 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2015 | 686 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1546 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2011 | 956 | 0.020 |
Why?
|
Sick Role | 1 | 2009 | 230 | 0.020 |
Why?
|
Estrogen Receptor alpha | 1 | 2012 | 580 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2016 | 10329 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2013 | 882 | 0.020 |
Why?
|
Vitamins | 1 | 2016 | 1635 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2003 | 7379 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2013 | 852 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2019 | 3291 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3754 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2015 | 981 | 0.020 |
Why?
|
Lipids | 1 | 2018 | 3337 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2007 | 5801 | 0.020 |
Why?
|
Social Environment | 1 | 2012 | 1019 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2019 | 58864 | 0.020 |
Why?
|
Mitochondrial Diseases | 1 | 2011 | 340 | 0.020 |
Why?
|
Genetic Variation | 1 | 2022 | 6531 | 0.020 |
Why?
|
Sickness Impact Profile | 1 | 2008 | 298 | 0.020 |
Why?
|
Signal Transduction | 1 | 2010 | 23328 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1634 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2017 | 2627 | 0.020 |
Why?
|
Social Adjustment | 1 | 2009 | 632 | 0.020 |
Why?
|
Leptin | 1 | 2014 | 1589 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4523 | 0.020 |
Why?
|
Threshold Limit Values | 1 | 2005 | 12 | 0.020 |
Why?
|
Calcium | 1 | 2019 | 5718 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9622 | 0.020 |
Why?
|
Social Stigma | 1 | 2012 | 730 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2018 | 3728 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 1665 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 2499 | 0.020 |
Why?
|
Water Supply | 1 | 2007 | 208 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2011 | 849 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5778 | 0.020 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1601 | 0.020 |
Why?
|
Respiratory Protective Devices | 1 | 2005 | 47 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2852 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3291 | 0.020 |
Why?
|
Maximum Allowable Concentration | 1 | 2005 | 63 | 0.020 |
Why?
|
Brain Diseases | 1 | 2014 | 1540 | 0.020 |
Why?
|
Stavudine | 1 | 2005 | 84 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 17748 | 0.020 |
Why?
|
Hospitals | 1 | 2018 | 3929 | 0.020 |
Why?
|
Serum Albumin | 1 | 2008 | 675 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 2007 | 466 | 0.010 |
Why?
|
Awareness | 1 | 2009 | 646 | 0.010 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2380 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2021 | 7838 | 0.010 |
Why?
|
Hepatitis A Antibodies | 1 | 2003 | 20 | 0.010 |
Why?
|
Mumps virus | 1 | 2003 | 23 | 0.010 |
Why?
|
Hepatitis A Vaccines | 1 | 2003 | 26 | 0.010 |
Why?
|
Mortality | 1 | 2015 | 2913 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2011 | 1825 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8520 | 0.010 |
Why?
|
Genital Neoplasms, Female | 1 | 2009 | 538 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4356 | 0.010 |
Why?
|
Mice | 7 | 2002 | 80993 | 0.010 |
Why?
|
Tetanus Toxoid | 1 | 2003 | 193 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1999 | 8050 | 0.010 |
Why?
|
Genitalia, Male | 1 | 2003 | 87 | 0.010 |
Why?
|
ROC Curve | 1 | 2011 | 3569 | 0.010 |
Why?
|
Population | 1 | 2003 | 140 | 0.010 |
Why?
|
Azithromycin | 1 | 2003 | 201 | 0.010 |
Why?
|
Biological Evolution | 1 | 2008 | 1071 | 0.010 |
Why?
|
Maternal Behavior | 1 | 2004 | 306 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12580 | 0.010 |
Why?
|
Tooth Loss | 1 | 2004 | 199 | 0.010 |
Why?
|
Recurrence | 2 | 2005 | 8465 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4563 | 0.010 |
Why?
|
Forecasting | 1 | 2011 | 2928 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9980 | 0.010 |
Why?
|
Placebos | 1 | 2005 | 1672 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2013 | 5100 | 0.010 |
Why?
|
Cesarean Section | 1 | 2009 | 1387 | 0.010 |
Why?
|
India | 1 | 2007 | 2344 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2005 | 12383 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3603 | 0.010 |
Why?
|
Siblings | 1 | 2004 | 825 | 0.010 |
Why?
|
Veterans | 1 | 2013 | 2628 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2002 | 578 | 0.010 |
Why?
|
Housing | 1 | 2004 | 662 | 0.010 |
Why?
|
Social Class | 1 | 2008 | 2005 | 0.010 |
Why?
|
Family | 1 | 2010 | 3189 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2058 | 0.010 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2002 | 859 | 0.010 |
Why?
|
Health Status | 1 | 2011 | 4079 | 0.010 |
Why?
|
Hemoglobins | 1 | 2002 | 1517 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2003 | 1053 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6530 | 0.010 |
Why?
|
Data Collection | 1 | 2005 | 3317 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5310 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2012 | 4732 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2010 | 3525 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2007 | 2474 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2004 | 5192 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15750 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2007 | 5414 | 0.010 |
Why?
|
Sepsis | 1 | 2007 | 2593 | 0.010 |
Why?
|
Genotype | 1 | 2007 | 12940 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2005 | 3730 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11903 | 0.010 |
Why?
|
Heart Diseases | 1 | 2002 | 2799 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 15262 | 0.000 |
Why?
|